SENSEX NIFTY

Gsk Pharma

Nov 08, 2016 at 15:00 | Source: CNBC-TV18
The US market is seeing a shift in market dynamics and several factors lead to drug product pricing and there will be further pricing pressure over the next few years, said GSK Global Chief Executive Andrew Witty.
Nov 04, 2016 at 08:00 | Source: CNBC-TV18
Tata Motors | Biocon | Berger Paints | GSK Pharma | GVK Power | GMR Infrastructure | Parsvnath Developers | Mphasis | Star Ferro | ESAB India | EIH | Coastal Corporation | FACT | Monsanto | TD Power | Chemfab Alkalies and Tube Investments are stocks, which are in the news today.
Oct 27, 2016 at 14:58 | Source: PTI
It had posted net profit of Rs 95.55 crore for the July- September period of the previous fiscal, GSK Pharma said in a BSE filing.
Oct 10, 2016 at 15:48 | Source: CNBC-TV18
Prakash Gaba of prakashgaba.com is of the view that one may hold GlaxoSmithKline Pharmaceuticals.
Sep 26, 2016 at 14:38 | Source: Moneycontrol.com
With maintaining neutral rating on Glaxosmithkline Pharmaceutical, Credit Suisse slashed target price to Rs 2,850 as it continues to struggle with price control & supply constraints in some products. It also reduced FY17 earnings per share by 41 percent.
Sep 15, 2016 at 19:49 | Source: Moneycontrol.com
Some investors shy away from buying stocks that have high prices. The belief is unfounded.
Jun 08, 2016 at 10:58 | Source: CNBC-TV18
Andrew Aristidou, CFO and ED Finance, GSK Pharma, speaks about the companys new launches and why GSK Pharma is in no rush to delist in India.
Mar 21, 2016 at 11:24 | Source: CNBC-TV18
Ajay Bodke of Prabhudas Lilladher is of the view that one can look at Ashok Leyland, Tata Motors, GlaxoSmithKline Consumer Healthcare, Britannia Industries and Sun Pharma.
Feb 11, 2016 at 08:13 | Source: CNBC-TV18
SBI | Tata Motors | HUL | Bharti Airtel | Cipla | ACC | Ambuja Cements | Emami | NHPC | Aurobindo Pharma | Visa Steel | Ruchi Soya | Venus Remedies | Financial Technologies | Tata Global | BL Kashyap | Asahi India Glass | IVRCL | Alstom T&D India | GSK Pharma and Capital First are stocks, which are in the news today.
Feb 10, 2016 at 17:00 | Source: CNBC-TV18
In an interview with CNBC-TV18, A Vaidheesh, VP, South Asia and MD of India GSK said that companys growth is in-line with the market and expects margins to outperform the industry average this fiscal.
Messages on Gsk Pharma »

Just Posted  

Gsk pharma

2.04 PM Oct 27th

multibagger
2014

New Member

17 Followers

GlaxoSmithKline  

gsk pharma - long overdue to cross 3000... may happen tomorrow...

4.09 PM Oct 26th

bmmehta1970

New Member

0 Follower

GlaxoSmithKline  

buy gsk pharma after result tgt 3200/-

3.15 PM Oct 18th

bmmehta1970

New Member

0 Follower

  

buy gsk pharma good fundamental mnc co

10.57 AM Oct 13th

bmmehta1970

New Member

0 Follower

GlaxoSmithKline  

in gsk pharma downfall is completed now only upmoveis there.

5.20 PM Oct 6th

bmmehta1970

New Member

0 Follower

GlaxoSmithKline  

buy gsk pharma now upmove is just started.

5.18 PM Oct 6th

Forum Messenger

Platinum Member

376165 Followers

GlaxoSmithKline  

Will you bet on GSK Pharma?

2.38 PM Sep 26th

GlaxoSmithKline Pharmaceuticals  

gsk pharma can shine post march 2017

1.06 PM Sep 19th

BSE/NSE Announcer

Platinum Member

19464 Followers

GlaxoSmithKline  

The Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals Ltd on August 31, 2016 with reference to news flashed on CNBC TV18 dated August 31, 2016 stating "GSK Pharma invites bid for 60 acre land parcel in Thane, valued at 1400-1800 Cr"The reply is awaited.

12.41 PM Aug 31st

rajesh2256

New Member

2 Followers

Standard Ind  

on CNBC today there is a news of gsk pharma likely to sell thane land to either rahejaa or pirnal. what is implications on standard Ind?

12.31 PM Aug 31st

News across the web »
Dec 23, 2014 at 21:30 | Source: FirstPost
Aug 24, 2014 at 18:32 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.